Jorge Sierra

机构：Universitat Autònoma de Barcelona, Hospital de Sant Pau, Josep Carreras Leukaemia Research Institute, Hospital Universitario Virgen del Rocío, Institut de Recerca Sant Pau, University of Lausanne · ORCID：0000-0002-7966-0356

发表论文 778 篇 · 总被引 40949 次 · h-index 76

代表论文

• Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations (2024 · Blood · 被引 242)
• Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy (2022 · Transplantation and Cellular Therapy · 被引 44)
• Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet (2025 · Blood Advances · 被引 29)
• Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort (2023 · Blood Cancer Journal · 被引 23)
• Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial (2023 · Blood Advances · 被引 22)
• Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature (2023 · Transplantation and Cellular Therapy · 被引 15)